Skip to end of metadata
Go to start of metadata



Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consulting
Jean Duteau (Chair)Duteau Designx
John Hatem (Scribe)Independent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCP
Isaac VetterEpic
Smile Digital Healthx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealandx
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHAx
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborative
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir

Joe KellySurescripts
Peter Jordan

Giorgio CangioliHL7 Italyx
Jose Costa Teixeira
Jeff ShickUSP
Kent BulzaArtera

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Proposals

Project Proposals in Review - none to review

Project Scope Statements

Project Scope Statements - none to review

External Meeting Review

Catalog Updates (John Hatem)

  • Working on trackers, no pharmacy-related issues came up

Workflow Update (John Hatem)

  • Updated Definition pattern from tracker.  No Pharmacy impact. 

Healthcare Product Update (John Hatem)

  • Trackers were discussed - no pharmacy impact. Discussed Nutrition Product, BDP, InventoryItem, InventoryReport

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem / Jimmy Tcheng)

NCPDP Updates (NCPDP Members)

Pharmacist Consult Note (Scott)

  • Scott waiting for input. 

Pharmacy Templates

  • FHIR-20669 issue raised by Giorgio - technical correction
  • FHIR-20668  see tracker for issues. Motion to accept proposed solution:  Giorgio/Jose  motion passed by 9-0-0
  • CDA-20494 and CDA-20493 issues.  Motion to accept proposal: ScottR/ Shelly motion passed by 9-0-0   See tracker for resolution and details. 

Specialty Medication Enrolment IG

  • Shelly reported this work is progressing. Developers identified/ seeking funding.  This issue may have an international impact e.g. Australian input.   

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

  • Jean has a resource working on making the changes
    • working on MedUsage name change completed - 
    • Feb 24 - all changes from ballot - then will be published as R5
    • Jean reported on the status of the work and updates to our trackers.  Many are in progress. 
  • FHIR-38662 discussed, see tracker for details - Motion by: Jose / Scott  vote: 9-0-0

Any Other Business

  • John reviewed the mapping between Med dispense status and BDP dispense status.  Suggestion was to send this to the list serve for input. 
  • FYI: Shelly reported on some US-CDI work Medication Adherence and Medication Instruction (SIG).  Target completion mid April. 

Next meeting: